OCGN vs. NVO
OCGN (Ocugen, Inc.) and NVO (Novo Nordisk A/S) are both stocks. Both are in the Healthcare sector — OCGN in Biotechnology, NVO in Drug Manufacturers - General. Over the past 10 years, OCGN returned -2.50%/yr vs 8.62%/yr for NVO. At a 0.13 correlation, their price movements are largely independent.
Performance
OCGN vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OCGN achieves a 2.96% return, which is significantly higher than NVO's -3.56% return. Over the past 10 years, OCGN has underperformed NVO with an annualized return of -2.50%, while NVO has yielded a comparatively higher 8.62% annualized return.
OCGN
- 1D
- 0.72%
- 1M
- 3.73%
- YTD
- 2.96%
- 6M
- -3.47%
- 1Y
- 34.30%
- 3Y*
- 37.93%
- 5Y*
- -30.13%
- 10Y*
- -2.50%
NVO
- 1D
- -0.02%
- 1M
- 5.45%
- YTD
- -3.56%
- 6M
- -6.64%
- 1Y
- -29.84%
- 3Y*
- -13.64%
- 5Y*
- 4.94%
- 10Y*
- 8.62%
OCGN vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
OCGN Ocugen, Inc. | 2.96% | 67.70% | 40.00% | -55.77% | -71.43% | 148.63% | 251.92% | 488.24% | -95.69% | 22.75% |
NVO Novo Nordisk A/S | -3.56% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
Correlation
The correlation between OCGN and NVO is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.18 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.13 |
Correlation (All Time) Calculated using the full available price history since Dec 3, 2014 | 0.13 |
The correlation between OCGN and NVO shifts across timeframes, from 0.13 (10 years) to 0.28 (1 year), reflecting how their relationship changes across market environments.
Fundamentals
OCGN:
$445.39M
NVO:
$210.91B
OCGN:
-$0.23
NVO:
DKK 27.42
OCGN:
95.63
NVO:
4.23
OCGN:
76.72
NVO:
6.83
OCGN:
$4.47M
NVO:
DKK 327.80B
OCGN:
$2.93M
NVO:
DKK 268.30B
OCGN:
-$64.77M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OCGN vs. NVO — Risk / Return Rank
OCGN
NVO
OCGN vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Ocugen, Inc. (OCGN) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| OCGN | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.01 | ||
| Sortino ratioReturn per unit of downside risk | +1.77 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.92 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 0.66 | -0.61 | +1.27 |
| Martin ratioReturn relative to average drawdown | 1.38 | -0.97 | +2.34 |
Loading charts...
Drawdowns
OCGN vs. NVO - Drawdown Comparison
The maximum OCGN drawdown since its inception was -99.25%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for OCGN and NVO.
Loading charts...
Drawdown Indicators
| OCGN | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.25% | -74.70% | -24.55% |
Max Drawdown (1Y)Largest decline over 1 year | -52.42% | -49.17% | -3.25% |
Max Drawdown (3Y)Largest decline over 3 years | -73.92% | -74.70% | +0.78% |
Max Drawdown (5Y)Largest decline over 5 years | -97.71% | -74.70% | -23.01% |
Max Drawdown (10Y)Largest decline over 10 years | -97.80% | -74.70% | -23.10% |
Current DrawdownCurrent decline from peak | -91.21% | -65.55% | -25.66% |
Average DrawdownAverage peak-to-trough decline | -81.75% | -17.82% | -63.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 25.01% | 30.93% | -5.92% |
Volatility
OCGN vs. NVO - Volatility Comparison
Ocugen, Inc. (OCGN) has a higher volatility of 15.39% compared to Novo Nordisk A/S (NVO) at 12.00%. This indicates that OCGN's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OCGN | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.39% | 12.00% | +3.39% |
Volatility (6M)Calculated over the trailing 6-month period | 63.41% | 38.40% | +25.01% |
Volatility (1Y)Calculated over the trailing 1-year period | 80.45% | 51.78% | +28.67% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 90.35% | 38.48% | +51.87% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 550.74% | 32.58% | +518.16% |
Dividends
OCGN vs. NVO - Dividend Comparison
OCGN has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.80%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.80% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
OCGN Ocugen, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
OCGN vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Ocugen, Inc. and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OCGN and NVO have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OCGN has higher volatility (15.39%) compared to NVO (12.00%). In terms of maximum drawdown, OCGN dropped -99.25% vs NVO's -74.70%.
OCGN currently has the higher Sharpe Ratio (0.43 vs -0.58), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OCGN and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer